Link Cell Therapies
PrivateLast Round
Series A
Dec 15, 2025
Total Funding Raised
$124M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Link Cell Therapies is a biotechnology company developing next-generation CAR-T cell therapies for the treatment of solid and liquid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Link Cell Therapies Comparables
Compare Link Cell Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inceptor Bio | 87% | |
| ArsenalBio | 85% | |
| AvenCell | 83% |
Link Cell Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2025 | ||||
| Seed | May 1, 2022 |
Link Cell Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wing Venture Capital | Series A |
| Wing Venture Capital | Series A |
| Sherpa Healthcare Partners | Series A |
| Samsara BioCapital | Series A, Seed |
| Johnson & Johnson Innovation – JJDC | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 58% MoM, from 1.3K to 2K.
- Jun 25, 2026
Grew 17% QoQ, from 24 to 28 employees.
Link Cell Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Link Cell Therapies's valuation, stock price, and market status.
Is Link Cell Therapies a public or private company?
Link Cell Therapies is a private company.
What is the current stock price of Link Cell Therapies?
Link Cell Therapies is a private company with no public stock price. No recent secondary market data is available.
How much is Link Cell Therapies worth (valuation)?
Valuation information for Link Cell Therapies is not publicly available.
Can I buy Link Cell Therapies stock?
Link Cell Therapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Link Cell Therapies's last funding round?
Link Cell Therapies's most recent funding round was Series A on December 15, 2025.
Who are the main investors in Link Cell Therapies?
Key investors in Link Cell Therapies include Samsara BioCapital, Johnson & Johnson Innovation - JJDC, Inc..
Will Link Cell Therapies IPO soon?
No public IPO plans have been announced for Link Cell Therapies.
How can I track Link Cell Therapies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Link Cell Therapies's secondary market activity and sign up for updates.